PMGC HOLDINGS INC. Interest Expense Nonoperating
PMGC HOLDINGS INC. (ELAB) reported Interest Expense Nonoperating of $582.24 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseNonoperating · last filed 2026-08-14
- PMGC HOLDINGS INC. interest expense nonoperating for the quarter ending 2026-06-30 was $582.24K, a 29111950.00% increase year-over-year.
- PMGC HOLDINGS INC. interest expense nonoperating for the quarter ending 2026-03-31 was $474.17K, a 4427.11% increase year-over-year.
- PMGC HOLDINGS INC. interest expense nonoperating for the quarter ending 2025-12-31 was $229.75K, a 353.87% increase year-over-year.
- PMGC HOLDINGS INC. interest expense nonoperating for the quarter ending 2025-09-30 was $17.40K, a 97.29% decline year-over-year.
- PMGC HOLDINGS INC. interest expense nonoperating for fiscal 2025 was $257.63K, a 64.96% decline from fiscal 2024.
- PMGC HOLDINGS INC. interest expense nonoperating for fiscal 2024 was $735.20K.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 3 month as first filed | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 6 month as first filed | Interest Expense Nonoperating 9 month | Interest Expense Nonoperating 9 month as first filed | Interest Expense Nonoperating 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $582.24K 10-Q · filed 2026-08-14 | $1.06M 10-Q · filed 2026-08-14 | $1.29M derived: sum of 3 quarters · filed 2026-08-14 | $1.30M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2026-03-31 | $474.17K 10-Q · filed 2026-05-15 | $703.92K derived: sum of 2 quarters · filed 2026-05-15 | $721.32K derived: sum of 3 quarters · filed 2026-05-15 | $721.33K derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-12-31 | $229.75K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $247.15K derived: sum of 2 quarters · filed 2026-03-30 | $247.16K derived: sum of 3 quarters · filed 2026-08-14 | $257.63K 10-K · filed 2026-03-30 | |||
| 2025-09-30 | $17.40K 10-Q · filed 2025-11-14 | $17.40K derived: sum of 2 quarters · filed 2026-08-14 | $27.88K 10-Q · filed 2025-11-14 | $78.50K derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-06-30 | $2.00 10-Q · filed 2026-08-14 | $10.48K 10-Q · filed 2026-08-14 | $61.10K derived: sum of 3 quarters · filed 2026-08-14 | $702.90K derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-03-31 | $10.47K 10-Q · filed 2026-05-15 | $61.09K derived: sum of 2 quarters · filed 2026-05-15 | $702.90K derived: sum of 3 quarters · filed 2026-05-15 | $726.50K derived: sum of 4 quarters · filed 2026-05-15 | |||
| 2024-12-31 | $50.62K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $692.43K derived: sum of 2 quarters · filed 2026-03-30 | $716.02K derived: sum of 3 quarters · filed 2026-03-30 | $735.20K 10-K · filed 2026-03-30 | |||
| 2024-09-30 | $641.81K 10-Q · filed 2025-11-14 | $648.33K 10-Q · filed 2024-11-14 | $665.40K derived: sum of 2 quarters · filed 2025-11-14 | $684.58K 10-Q · filed 2025-11-14 | $702.67K 10-Q · filed 2024-11-14 | ||
| 2024-06-30 | $23.60K 10-Q · filed 2025-08-13 | $30.81K 10-Q · filed 2024-08-14 | $42.77K 10-Q · filed 2025-08-13 | $54.34K 10-Q · filed 2024-08-14 | |||
| 2024-03-31 | $19.17K 10-Q · filed 2025-05-14 | ||||||
| 2023-09-30 | $5.71K 10-Q · filed 2024-11-14 | $10.12K derived: sum of 2 quarters · filed 2024-11-14 | $12.76K 10-Q · filed 2024-11-14 | ||||
| 2023-06-30 | $4.41K 10-Q · filed 2024-08-14 | $7.04K 10-Q · filed 2024-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B |